An Experimental Gene Therapy for Cerebral ALD Has Been Granted Breakthrough Therapy Designation by the FDA
The U.S. Food and Drug Administration has granted Breakthrough Therapy designation to the experimental drug Lenti-D, which is being produced by the gene therapy company Bluebird bio to treat cerebral…